Feedback
LeukoStrat CDx FLT3 Mutation Detection by PCR
2014683
Ordering Recommendation

Aid in the assessment of acute myeloid leukemia patients for whom midostaurin (RYDAPT) treatment is being considered.

Mnemonic
FLT3 CDX
Methodology
Qualitative Polymerase Chain Reaction/Capillary Electrophoresis
Performed
Varies
Reported
3-5 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Green (Sodium Heparin). 
Specimen Preparation
Transport 3 mL whole blood. (Min: 1 mL) OR Transport 1 mL bone marrow. (Min: 0.25 mL) Separate specimens must be submitted when multiple tests are ordered. 
Storage/Transport Temperature
Refrigerated. 
Unacceptable Conditions
Specimens in Bone Marrow transport media. Grossly hemolyzed or clotted specimens. 
Remarks
Specimen type required. 
Stability
Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable 
Reference Interval
Interpretive Data


Note
Hotline History
View Hotline History
Components
Component Test Code*Component Chart NameLOINC
2014684LeukoStrat CDx FLT3 - Specimen Type31208-2
2014685LeukoStrat CDx FLT3 Mutation Detection19146-0
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases

Performed at LabPMM